Japanese flu vaccine makers jack up price ahead of flu season; Supreme Court won't hear challenge to NY public schools vaccination requirement;

> Four Japanese flu vaccine makers have hiked their prices by 50% just ahead of the flu season. Story

> The Supreme Court will not hear a challenge to New York state's requirement that children get vaccinated before starting public school. Article

> Abivax is evaluating HeberNavasc, the new Cuban vaccine for the treatment of chronic hepatitis B in 8 countries. More

Suggested Articles

GSK expects Shingrix supplies to rise slightly in 2020, but the real "step change" will come in 2024 with a brand-new manufacturing facility.

Ebola has claimed thousands of lives in recent outbreaks, but now the world has a licensed vaccine option in Merck's Ervebo.

Cosette Pharmaceuticals which was formed in December with a deal for dermatology projects has gone back to G&W Labs for a liquids plant.